Literature DB >> 17652523

Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.

Sarah S Bubeck1, Peter H Dube.   

Abstract

An in-frame deletion of the yopH gene in Yersinia pestis CO92 attenuates virulence in both bubonic and pneumonic plague models. When it is used as a live, attenuated vaccine, CO92 delta yopH provides a high degree of protection from parental and respiratory challenge with Y. pestis CO92.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17652523      PMCID： PMC2043315          DOI： 10.1128/CVI.00137-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  36 in total

1.  Plague, Democratic Republic of The Congo.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2005-02-25

2.  [Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge].

Authors:  E Bertherat; K M Lamine; P Formenty; P Thuier; V Mondonge; A Mitifu; L Rahalison
Journal:  Med Trop (Mars)       Date:  2005-11

3.  Nucleotide sequence and transcription analysis of yop51 from Yersinia enterocolitica W22703.

Authors:  T Michiels; G Cornelis
Journal:  Microb Pathog       Date:  1988-12       Impact factor: 3.738

4.  Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs.

Authors:  K F Meyer; G Smith; L Foster; M Brookman; M Sung
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

5.  Human immune response to a plague vaccine comprising recombinant F1 and V antigens.

Authors:  E D Williamson; H C Flick-Smith; C Lebutt; C A Rowland; S M Jones; E L Waters; R J Gwyther; J Miller; P J Packer; M Irving
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Pneumonic plague in an untreated plague-vaccinated individual.

Authors:  R J Cohen; J L Stockard
Journal:  JAMA       Date:  1967-10-23       Impact factor: 56.272

7.  Genome sequence of Yersinia pestis, the causative agent of plague.

Authors:  J Parkhill; B W Wren; N R Thomson; R W Titball; M T Holden; M B Prentice; M Sebaihia; K D James; C Churcher; K L Mungall; S Baker; D Basham; S D Bentley; K Brooks; A M Cerdeño-Tárraga; T Chillingworth; A Cronin; R M Davies; P Davis; G Dougan; T Feltwell; N Hamlin; S Holroyd; K Jagels; A V Karlyshev; S Leather; S Moule; P C Oyston; M Quail; K Rutherford; M Simmonds; J Skelton; K Stevens; S Whitehead; B G Barrell
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

Review 8.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Effects of growth temperature, 47-megadalton plasmid, and calcium deficiency on the outer membrane protein porin and lipopolysaccharide composition of Yersinia pestis EV76.

Authors:  R P Darveau; W T Charnetzky; R F Hurlbert; R E Hancock
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens.

Authors:  Audrey Glynn; Lucy C Freytag; John D Clements
Journal:  Vaccine       Date:  2005-03-14       Impact factor: 3.641
View more
  22 in total

1.  NMR-based design and evaluation of novel bidentate inhibitors of the protein tyrosine phosphatase YopH.

Authors:  Marilisa Leone; Elisa Barile; Jesus Vazquez; Angel Mei; Donald Guiney; Russel Dahl; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-04-28       Impact factor: 2.817

Review 2.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Pulmonary infection by Yersinia pestis rapidly establishes a permissive environment for microbial proliferation.

Authors:  Paul A Price; Jianping Jin; William E Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-01       Impact factor: 11.205

Review 4.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

5.  Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion.

Authors:  Addie Embry; Xiangzhi Meng; Angelene Cantwell; Peter H Dube; Yan Xiang
Journal:  Vaccine       Date:  2011-06-12       Impact factor: 3.641

6.  YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.

Authors:  Yue Zhang; James B Bliska
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

7.  YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia.

Authors:  Angelene M Cantwell; Sarah S Bubeck; Peter H Dube
Journal:  BMC Immunol       Date:  2010-06-16       Impact factor: 3.615

8.  D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.

Authors:  Frank M Szaba; Lawrence W Kummer; Lindsey B Wilhelm; Jr-Shiuan Lin; Michelle A Parent; Sara W Montminy-Paquette; Egil Lien; Lawrence L Johnson; Stephen T Smiley
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

9.  A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection.

Authors:  Petra C F Oyston; Gabriela Mellado-Sanchez; Marcela F Pasetti; James P Nataro; Richard W Titball; Helen S Atkins
Journal:  Microb Pathog       Date:  2010-01-22       Impact factor: 3.738

10.  The role of relA and spoT in Yersinia pestis KIM5 pathogenicity.

Authors:  Wei Sun; Kenneth L Roland; Christine G Branger; Xiaoying Kuang; Roy Curtiss
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.